Risk factors to cause tooth formation anomalies in chemotherapy of paediatric cancers

S. Nishimura, H. Inada, Yoshihiko Sawa, H. Ishikawa

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

This study aimed to investigate the risk factors of tooth formation anomalies in anti-cancer chemotherapies. Long-term survivors treated by conventional chemotherapy (n = 26), conventional chemotherapy with high-dose chemotherapy (HDC) (n = 14), and HDC with total body irradiation (TBI) (n = 6) were analysed for the incidence of tooth agenesis, microdonts, and short-rooted teeth. The tooth agenesis and/or microdonts were found in second premolars and second molars, but not in first molars or central incisors. The ratio of subjects with tooth agenesis and/or microdonts was 66.7% and 18.2% in subjects administered conventional chemotherapy at <4 years and ≥4 years of age, respectively, while it was 100% and 25% in subjects administered HDC at <4 years and ≥4 years of age. The incidence of tooth formation anomalies did not related with the duration of conventional chemotherapy but increased by HDC. The incidence of tooth formation anomalies did not show significantly differences between the HDC with and without TBI groups, and was higher in busulfan-administered subjects than in subjects given cyclophosphamide. It may be concluded that the high-risk group of tooth agenesis is the subjects with HDC under 4 years of age. However, protocols of conventional chemotherapy are not an important risk factor to cause the tooth formation anomalies.

Original languageEnglish
Pages (from-to)353-360
Number of pages8
JournalEuropean Journal of Cancer Care
Volume22
Issue number3
DOIs
Publication statusPublished - May 2013
Externally publishedYes

Fingerprint

Tooth
Pediatrics
Drug Therapy
Neoplasms
Whole-Body Irradiation
Incidence
Busulfan
Bicuspid
Incisor
Cyclophosphamide
Survivors

Keywords

  • Anti-cancer chemotherapy
  • Growth and development
  • Medical disability
  • Orthodontics
  • Tooth formation anomalies

ASJC Scopus subject areas

  • Oncology

Cite this

Risk factors to cause tooth formation anomalies in chemotherapy of paediatric cancers. / Nishimura, S.; Inada, H.; Sawa, Yoshihiko; Ishikawa, H.

In: European Journal of Cancer Care, Vol. 22, No. 3, 05.2013, p. 353-360.

Research output: Contribution to journalArticle

@article{fbcee25be85a47f49fb1cf5032bac553,
title = "Risk factors to cause tooth formation anomalies in chemotherapy of paediatric cancers",
abstract = "This study aimed to investigate the risk factors of tooth formation anomalies in anti-cancer chemotherapies. Long-term survivors treated by conventional chemotherapy (n = 26), conventional chemotherapy with high-dose chemotherapy (HDC) (n = 14), and HDC with total body irradiation (TBI) (n = 6) were analysed for the incidence of tooth agenesis, microdonts, and short-rooted teeth. The tooth agenesis and/or microdonts were found in second premolars and second molars, but not in first molars or central incisors. The ratio of subjects with tooth agenesis and/or microdonts was 66.7{\%} and 18.2{\%} in subjects administered conventional chemotherapy at <4 years and ≥4 years of age, respectively, while it was 100{\%} and 25{\%} in subjects administered HDC at <4 years and ≥4 years of age. The incidence of tooth formation anomalies did not related with the duration of conventional chemotherapy but increased by HDC. The incidence of tooth formation anomalies did not show significantly differences between the HDC with and without TBI groups, and was higher in busulfan-administered subjects than in subjects given cyclophosphamide. It may be concluded that the high-risk group of tooth agenesis is the subjects with HDC under 4 years of age. However, protocols of conventional chemotherapy are not an important risk factor to cause the tooth formation anomalies.",
keywords = "Anti-cancer chemotherapy, Growth and development, Medical disability, Orthodontics, Tooth formation anomalies",
author = "S. Nishimura and H. Inada and Yoshihiko Sawa and H. Ishikawa",
year = "2013",
month = "5",
doi = "10.1111/ecc.12038",
language = "English",
volume = "22",
pages = "353--360",
journal = "European Journal of Cancer Care",
issn = "0961-5423",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Risk factors to cause tooth formation anomalies in chemotherapy of paediatric cancers

AU - Nishimura, S.

AU - Inada, H.

AU - Sawa, Yoshihiko

AU - Ishikawa, H.

PY - 2013/5

Y1 - 2013/5

N2 - This study aimed to investigate the risk factors of tooth formation anomalies in anti-cancer chemotherapies. Long-term survivors treated by conventional chemotherapy (n = 26), conventional chemotherapy with high-dose chemotherapy (HDC) (n = 14), and HDC with total body irradiation (TBI) (n = 6) were analysed for the incidence of tooth agenesis, microdonts, and short-rooted teeth. The tooth agenesis and/or microdonts were found in second premolars and second molars, but not in first molars or central incisors. The ratio of subjects with tooth agenesis and/or microdonts was 66.7% and 18.2% in subjects administered conventional chemotherapy at <4 years and ≥4 years of age, respectively, while it was 100% and 25% in subjects administered HDC at <4 years and ≥4 years of age. The incidence of tooth formation anomalies did not related with the duration of conventional chemotherapy but increased by HDC. The incidence of tooth formation anomalies did not show significantly differences between the HDC with and without TBI groups, and was higher in busulfan-administered subjects than in subjects given cyclophosphamide. It may be concluded that the high-risk group of tooth agenesis is the subjects with HDC under 4 years of age. However, protocols of conventional chemotherapy are not an important risk factor to cause the tooth formation anomalies.

AB - This study aimed to investigate the risk factors of tooth formation anomalies in anti-cancer chemotherapies. Long-term survivors treated by conventional chemotherapy (n = 26), conventional chemotherapy with high-dose chemotherapy (HDC) (n = 14), and HDC with total body irradiation (TBI) (n = 6) were analysed for the incidence of tooth agenesis, microdonts, and short-rooted teeth. The tooth agenesis and/or microdonts were found in second premolars and second molars, but not in first molars or central incisors. The ratio of subjects with tooth agenesis and/or microdonts was 66.7% and 18.2% in subjects administered conventional chemotherapy at <4 years and ≥4 years of age, respectively, while it was 100% and 25% in subjects administered HDC at <4 years and ≥4 years of age. The incidence of tooth formation anomalies did not related with the duration of conventional chemotherapy but increased by HDC. The incidence of tooth formation anomalies did not show significantly differences between the HDC with and without TBI groups, and was higher in busulfan-administered subjects than in subjects given cyclophosphamide. It may be concluded that the high-risk group of tooth agenesis is the subjects with HDC under 4 years of age. However, protocols of conventional chemotherapy are not an important risk factor to cause the tooth formation anomalies.

KW - Anti-cancer chemotherapy

KW - Growth and development

KW - Medical disability

KW - Orthodontics

KW - Tooth formation anomalies

UR - http://www.scopus.com/inward/record.url?scp=84876852602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876852602&partnerID=8YFLogxK

U2 - 10.1111/ecc.12038

DO - 10.1111/ecc.12038

M3 - Article

C2 - 23336315

AN - SCOPUS:84876852602

VL - 22

SP - 353

EP - 360

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

SN - 0961-5423

IS - 3

ER -